Literature DB >> 13856636

GOLD therapy in rheumatoid arthritis. Report of a multicentre control trial.

.   

Abstract

Entities:  

Keywords:  GOLD/therapy

Mesh：

Substances：

Year:  1960        PMID： 13856636      PMCID： PMC1007132     

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

1.  Gold in the treatment of rheumatoid arthritis.

Authors:  L M LOCKIE; B M NORCROSS; D J RIORDAN
Journal:  J Am Med Assoc       Date:  1958-07-05

2.  Observations on gold therapy in rheumatoid arthritis.

Authors:  R A P BROWN; J P CURRIE
Journal:  Br Med J       Date:  1953-04-25

3.  CONTROLLED EVALUATION OF GOLD THERAPY IN RHEUMATOID ARTHRITIS.

Authors:  H Waine; F Baker; S R Mettier
Journal:  Calif Med       Date:  1947-05

4.  Gold Treatment in Rheumatoid Arthritis.

Authors:  T N Fraser
Journal:  Ann Rheum Dis       Date:  1945-06       Impact factor: 19.103

5.  Clinical evaluation of aurothioglycolanilide (Lauron-Endo) in rheumatoid arthritis.

Authors:  R R MERLISS; B AXELROD; J FINEBERG; M MELNIK
Journal:  Ann Intern Med       Date:  1951-08       Impact factor: 25.391

6.  Rheumatoid arthritis, sanocrysin treatment and prognosis.

Authors:  E SNORRASON
Journal:  Acta Med Scand       Date:  1952-03-19

7.  Gold therapy in early rheumatoid arthritis.

Authors:  C H ADAMS; R L CECIL
Journal:  Ann Intern Med       Date:  1950-07       Impact factor: 25.391
  7 in total
  26 in total

1.  In rheumatoid arthritis is compliance in physicians more of a problem than compliance in patients?

Authors:  R J Rooney; W W Buchanan
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

2.  Unique properties of auranofin as a potential anti-rheumatic drug.

Authors:  M L Barrett; G P Lewis
Journal:  Agents Actions       Date:  1986-10

Review 3.  Monitoring gold plasma levels in rheumatoid arthritis.

Authors:  A Lorber
Journal:  Clin Pharmacokinet       Date:  1977 Mar-Apr       Impact factor: 6.447

Review 4.  Joint damage in rheumatoid arthritis: radiological assessments and the effects of anti-rheumatic drugs.

Authors:  D L Scott; P A Bacon
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

5.  Aurothioglucose overdosage in five patients with rheumatoid arthritis.

Authors:  I Rubinstein; P Langevitz; M Pras
Journal:  Clin Rheumatol       Date:  1987-12       Impact factor: 2.980

Review 6.  What happens to patients with rheumatoid arthritis? The long-term outcome of treatment.

Authors:  T D Spector; D L Scott
Journal:  Clin Rheumatol       Date:  1988-09       Impact factor: 2.980

Review 7.  Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.

Authors:  M Chaffman; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

8.  Auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Cooperative systematic studies of rheumatic diseases.

Authors:  H J Williams; J R Ward; M J Egger; J C Reading; C O Samuelson; M Altz-Smith; R W Willkens; M A Solsky; S P Hayes; D Furst
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980

9.  Randomized trial of switching rheumatoid arthritis patients in remission with injectable gold to auranofin.

Authors:  P E Prete; J Zane; M Krailo; M Bulanowski
Journal:  Clin Rheumatol       Date:  1994-03       Impact factor: 2.980

Review 10.  Methotrexate intolerance in elderly patients with rheumatoid arthritis: what are the alternatives?

Authors:  Alexandros Drosos
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.